American Century Companies
GH icon

American Century Companies’s Guardant Health GH Stock Holding History

American Century Companies’s Portfolio GH Stock Details GH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$80.1M Buy
867,537
+787,934
+990% +$79.1M 0.04% 530
2025
Q4 		$8.13M Buy
79,603
+1,112
+1% +$99.5K ﹤0.01% 1545
2025
Q3 		$4.9M Sell
78,491
-17,563
-18% -$955K ﹤0.01% 1716
2025
Q2 		$5M Sell
96,054
-8,152
-8% -$364K ﹤0.01% 1668
2025
Q1 		$4.44M Buy
104,206
+282
+0.3% +$12.2K ﹤0.01% 1656
2024
Q4 		$3.17M Sell
103,924
-2,696
-3% -$75.8K ﹤0.01% 1807
2024
Q3 		$2.45M Hold
106,620
– – ﹤0.01% 1885
2024
Q2 		$3.08M Sell
106,620
-265
-0.2% -$6.17K ﹤0.01% 1719
2024
Q1 		$2.21M Hold
106,885
– – ﹤0.01% 1849
2023
Q4 		$2.89M Sell
106,885
-844
-0.8% -$22.1K ﹤0.01% 1613
2023
Q3 		$3.19M Sell
107,729
-1,180
-1% -$41.5K ﹤0.01% 1509
2023
Q2 		$3.9M Buy
108,909
+2,634
+2% +$75.6K ﹤0.01% 1400
2023
Q1 		$2.49M Sell
106,275
-106
-0.1% -$3.03K ﹤0.01% 1527
2022
Q4 		$2.89M Sell
106,381
-14,526
-12% -$665K ﹤0.01% 1438
2022
Q3 		$6.51M Buy
120,907
+1,612
+1% +$82.8K 0.01% 1026
2022
Q2 		$4.81M Sell
119,295
-938,575
-89% -$46.5M ﹤0.01% 1128
2022
Q1 		$70.1M Buy
1,057,870
+52,772
+5% +$3.61M 0.05% 370
2021
Q4 		$101M Buy
1,005,098
+361,498
+56% +$37.4M 0.06% 314
2021
Q3 		$80.5M Buy
643,600
+407,605
+173% +$48.4M 0.06% 346
2021
Q2 		$29.3M Buy
235,995
+31,178
+15% +$4.19M 0.02% 598
2021
Q1 		$31.3M Buy
204,817
+107,933
+111% +$16.3M 0.02% 538
2020
Q4 		$12.5M Buy
+96,884
New +$11.1M 0.01% 725

Other funds holding GH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

American Century Companies's GH Position: Q1 2026 in Review

American Century Companies increased its Guardant Health (GH) stake by 990% in Q1 2026, buying an estimated $79.1M and bringing the position to 867,537 shares worth $80.1M. The position accounts for 0.04% of the portfolio, ranked #530.

American Century Companies first reported a position in GH in Q4 2020 and has held it in 22 quarters since. The position peaked at $101M in Q4 2021. 481 funds tracked by Wall St. Rank hold GH as of Q1 2026.

  • American Century Companies held 867,537 shares of Guardant Health worth $80.1M as of Q1 2026.
  • American Century Companies bought 787,934 Guardant Health shares in Q1 2026, an estimated $79.1M.
  • Guardant Health made up 0.04% of American Century Companies's portfolio in Q1 2026, its #530 holding.
  • American Century Companies first reported a position in Guardant Health in Q4 2020 and has held it in 22 quarters since.
  • American Century Companies's Guardant Health position peaked at $101M in Q4 2021.
  • 481 funds tracked by Wall St. Rank held Guardant Health as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.